| --- |
| license: cc-by-4.0 |
| pretty_name: Compounded Sourcing Platform Index |
| language: |
| - en |
| size_categories: |
| - n<1K |
| tags: |
| - tabular |
| - healthcare |
| - procurement |
| - pharmacy |
| - b2b |
| - open-data |
| configs: |
| - config_name: default |
| data_files: "*.csv" |
| comment: "#" |
| --- |
| |
| # Compounded Sourcing Platform Index |
|
|
| What 12 compounded-medication sourcing platforms publish to licensed clinics, scored on 7 weighted operational criteria. |
| Every score was read from the platform's own public pages on 31 August 2026 (the `verified_at` column). Two more platforms |
| in this market are listed with the reason they were not scored. |
|
|
| Clinic Partner Guide, a B2B research and comparison publication for clinics comparing suppliers, publishes the index at |
| https://clinicpartnerguide.com/sourcing-platform-index/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings. This repository holds a copy of the files published there on that date. |
| The source page is canonical. |
| |
| The index records what platforms publish, not how they perform. It makes no clinical assessment: it does not assess clinical |
| quality, formulation quality or patient outcomes, and it contains no clinical guidance. |
| |
| ### Disclosure |
| |
| Avanta Pharma Group is the highest-scoring platform in this version (5.0 of 5, scored 2026-08-31). |
| |
| > Disclosure: Clinic Partner Guide has a commercial affiliation with Avanta Pharma Group. Avanta is scored on the same criteria as every platform in the index, and no payment changes a score, a rank or an award. See our commercial disclosure: https://clinicpartnerguide.com/commercial-disclosure/ |
| |
| ### Who it is for |
| |
| Clinic owners, med spa and weight-management operators, practice managers, procurement leads and the consultants who advise them, |
| when shortlisting suppliers; and researchers and reporters who cover clinic procurement. |
| |
| ### What is in it |
| |
| - 12 scored platforms: 5 multi-pharmacy marketplaces, 4 directories, 1 GPO or buying network, 1 quote engine and 1 direct supply partner. |
| - 2 platforms listed as not scored (category `Not scored`), with the reason in each `_reason` column. |
| - 84 criterion cells (12 platforms, 7 criteria). 12 are recorded as not stated: 6 in turnaround, 5 in pricing transparency, 1 in security posture. |
| - All 84 criterion cells cite a published page. |
|
|
| ### How the scores are made |
|
|
| Summary of the published methodology (v1.0, updated August 2026): https://clinicpartnerguide.com/methodology/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings |
| |
| - Weights: ordering workflow, pricing transparency and direct accountability 20% each; multi-state coverage, turnaround, |
| security posture and onboarding speed 10% each. |
| - Scale 0 to 5. `overall_of_5` is the weighted mean of the criteria a platform published enough to be judged on. |
| - A criterion neither published nor confirmed to Clinic Partner Guide is recorded as unknown and excluded from the weighted |
| average rather than scored low. Two overall scores can therefore rest on different amounts of evidence, so read |
| `criteria_evidenced_pct` beside `overall_of_5`. In this version it runs from 60% to 100%. |
| - The methodology also accepts a fact a platform confirms directly to Clinic Partner Guide, recorded with the date and the person |
| who confirmed it. In this version every cell rests on a published page. |
| - Scores are a snapshot of what each platform published on the date shown. Platform pages can change after 31 August 2026. |
| |
| ### Files |
| |
| | File | Contents | |
| |---|---| |
| | `sourcing-platform-index-2026-08-31.csv` | 14 data rows, 28 columns. The first six lines begin with `#` and hold the title, source, license, attribution and scoring date; the header is line 7. In pandas: `pd.read_csv(path, comment="#")`. | |
| | `sourcing-platform-index.json` | The same index as nested JSON: dataset metadata (source, methodology, scoredAt, license, scale), the 7 criteria with weights and definitions, 12 scored platforms and 2 unscored platforms with reasons. | |
|
|
| ### Columns (CSV) |
|
|
| | Column | Meaning | |
| |---|---| |
| | `platform`, `host`, `category` | The supplier, its website and its kind of business | |
| | `overall_of_5` | Weighted score, 0 to 5 (empty for rows not scored) | |
| | `criteria_evidenced_pct` | Share of criteria weight the platform published enough on to be judged | |
| | `verified_at` | Date the pages were read: 2026-08-31 for every row | |
| | `primary_document_url` | A price list or terms page, where one is published (empty otherwise) | |
| | `<criterion>_score` | 0 to 5; empty where nothing was stated | |
| | `<criterion>_source` | Where the score comes from (`published page` in this version) | |
| | `<criterion>_reason` | The sentence justifying the score | |
|
|
| Criterion keys: `ordering-workflow`, `pricing-transparency`, `direct-accountability`, `multi-state-coverage`, `turnaround`, |
| `security-posture`, `onboarding-speed`. |
|
|
| ### Regulatory context |
|
|
| FDA's shortage listings for tirzepatide (December 2024) and semaglutide (February 2025) have ended, and FDA has since acted against marketing of compounded GLP-1s; what a 503A pharmacy may compound is patient-specific and varies by state. Source: fda.gov, "FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize", read 2026-09-26. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize |
|
|
| ### License and attribution |
|
|
| License: CC BY 4.0, https://creativecommons.org/licenses/by/4.0/ |
|
|
| Attribution: Compounded Sourcing Platform Index, clinicpartnerguide.com |
|
|
| Keep the scoring date with any table you reuse. |
|
|
| ### How to cite |
|
|
| Compounded Sourcing Platform Index, clinicpartnerguide.com, scored 2026-08-31, CC BY 4.0. https://clinicpartnerguide.com/sourcing-platform-index/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings |
| |
| @misc{cpg_sourcing_platform_index_2026, |
| title = {Compounded Sourcing Platform Index}, |
| author = {{Clinic Partner Guide}}, |
| year = {2026}, |
| note = {Scored 2026-08-31. Licensed CC BY 4.0}, |
| howpublished = {\url{https://clinicpartnerguide.com/sourcing-platform-index/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings}} |
| } |
| |
| ### Source and updates |
|
|
| - Canonical page: https://clinicpartnerguide.com/sourcing-platform-index/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings |
| - Live files: https://clinicpartnerguide.com/sourcing-platform-index.csv?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings and https://clinicpartnerguide.com/sourcing-platform-index.json?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings |
| - Background: https://clinicpartnerguide.com/research/compounding-sourcing-platforms-open-data/?utm_source=cpg-desk&utm_medium=email&utm_campaign=2026-09-26-asset-dataset-listings |
| - A fixed re-scoring schedule is not published. Check `verified_at` here, and the source page for the current version. |
| - Questions about the data: partners@clinicpartnerguide.com |
